Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Factorial Design

Factorial Design

Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...

Hazard Ratio

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

Randomized Experiments

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...

Crossover Experiments

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same author

Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in HPV-positive oropharyngeal cancer (ReACT 1.0): an exploratory phase II trial.

Nature communications·2026

Same author

Myeloma Precursors Erode Durable Immunity: Results of the IMPACT study.

Research square·2026

Same author

Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.

Nature medicine·2026

Same author

Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study.

Nature communications·2026

Same author

Harmonized Estimation of Subgroup-Specific Treatment Effects in Randomized Trials: The Use of External Control Data.

Journal of the Royal Statistical Society. Series B, Statistical methodology·2026

Same journal

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026

Same journal

Towards optimal environmental policies: policy learning under arbitrary bipartite network interference.

Biostatistics (Oxford, England)·2026

Same journal

Multilevel functional quantile principal component analysis.

Biostatistics (Oxford, England)·2026

Same journal

Adaptive transfer learning for time-to-event modeling with applications in disease risk assessment.

Biostatistics (Oxford, England)·2026

Same journal

High-dimensional test for one-sided hypotheses.

Biostatistics (Oxford, England)·2026

Same journal

NBSR: a Negative Binomial Softmax Regression model for microRNA-seq data analysis.

Biostatistics (Oxford, England)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 4, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Uncertainty directed factorial clinical trials.

Gopal Kotecha^1,2, Steffen Ventz³, Sandra Fortini⁴

¹Department of Biostatistics, Harvard School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA.

Biostatistics (Oxford, England)

|February 8, 2024

Summary

This summary is machine-generated.

This study introduces Bayesian response-adaptive designs for factorial clinical trials. These adaptive designs optimize treatment allocation based on accumulating data, aiming to maximize trial objectives more efficiently than traditional methods.

Keywords:

Bayesian designs Factorial designs Information gain Multi-arm clinical trials Optimal designs Response-adaptive randomization

More Related Videos

Experimental Research Examining How People Can Cope with Uncertainty Through Soft Haptic Sensations

Experimental Research Examining How People Can Cope with Uncertainty Through Soft Haptic Sensations

Published on: September 16, 2015

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Related Experiment Videos

Last Updated: Jul 4, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Experimental Research Examining How People Can Cope with Uncertainty Through Soft Haptic Sensations

Experimental Research Examining How People Can Cope with Uncertainty Through Soft Haptic Sensations

Published on: September 16, 2015

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Area of Science:

Clinical Trials
Biostatistics
Bayesian Methodology

Background:

Factorial clinical trials are crucial for evaluating novel treatment combinations and identifying optimal strategies.
Traditional factorial designs often use balanced randomization, which may not be optimal for all trial objectives.
There is a need for adaptive designs that can efficiently allocate patients to treatment combinations based on emerging data.

Purpose of the Study:

To introduce a class of Bayesian response-adaptive designs for factorial clinical trials with binary outcomes.
To develop an algorithm that adapts randomization probabilities based on a specified utility function representing trial aims.
To compare the performance of these novel adaptive designs against traditional designs.

Main Methods:

Developed Bayesian decision-theoretic arguments to create response-adaptive randomization for factorial trials.
Incorporated investigator-defined utility functions to guide the adaptive algorithm.
Conducted comparative simulation studies using realistic scenarios from perioperative care, smoking cessation, and infectious disease prevention trials.

Main Results:

The proposed Bayesian response-adaptive designs demonstrated potential advantages over traditional designs in simulation studies.
Different utility functions led to tailored factorial designs with distinct operating characteristics.
Asymptotic behavior of the adaptive designs was investigated, providing theoretical insights.

Conclusions:

Bayesian response-adaptive designs offer a flexible and potentially more efficient approach for factorial clinical trials.
These adaptive strategies can be tailored to specific trial goals, such as estimating intervention effects or finding synergistic combinations.
The findings suggest that adaptive randomization can improve the efficiency and effectiveness of factorial trial designs in various medical fields.